ArticleBMC primary care2026
Design and evaluation of an implementation strategy of a diabetic foot program in primary care: study protocol for a cluster randomized controlled trial (iMplanta study).
Article in BMC primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07004179 (Implementation of a Diabetic Foot Prevention Strategy in Primary Care), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Implementation of a Diabetic Foot Prevention Strategy in Primary Care: Study Protocol for Two-arm Cluster Randomised Controlled Trial (iMplanta Study)
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundDiabetic foot is one of the most severe complications of diabetes mellitus, with physical, psychological, social, and economic consequences. Evidence suggests that up to 75-80% of diabetic foot complications are preventable through appropriate preventive care. Although structured preventive protocols, such as the Diabetic Foot Program, have been adapted for the primary care in Spain, their integration into routine clinical practice remains suboptimal. This paper describes the protocol for the iMplanta study, which aims to evaluate the effectiveness of an implementation strategy for the Diabetic Foot Program in primary care.
methodsThe iMplanta study is a two-arm cluster randomized controlled trial to be conducted in 20 primary care centres (PCCs) in Mallorca (Balearic Islands, Spain). PCCs will be randomly allocated (1:1) to either an intervention group or a control group. The intervention group will receive a structured implementation strategy for the Diabetic Foot Program developed using the Implementation Mapping framework, while the control group will continue with usual care, applying the Diabetic Foot Program without additional implementation support. Data will be collected at three time points: baseline (covering the 12 months prior to study initiation) and 6 and 12 months post-implementation. Implementation outcomes will be evaluated using the RE-AIM framework (reach, effectiveness, adoption, implementation, and maintenance), complemented by Proctor et al. implementation outcomes (acceptability, feasibility, and appropriateness). DISCUSSION: This study will generate evidence on how to effectively implement a preventive Diabetic Foot Program in real-world primary care. By applying implementation science principles, iMplanta aims to inform sustainable and transferable implementation strategies to increase uptake of evidence-based diabetic foot prevention and improve care delivery for people living with diabetes.
trial registrationProspectively registered on ClinicalTrials.gov, no. NCT07004179. Date of registration February 20, 2025.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.